KALA BIO announces 1-for-50 reverse stock split effective May 8, 2026

KALA BIO, Inc.

Reverse stock split at 1-for-50 ratio effective 4:05 p.m. ET on May 8, 2026.
Outstanding shares reduced from 929,491,578 to ~18,589,832; no fractional shares issued.
Cash paid for fractional shares based on May 7 closing price on Nasdaq Capital Market.
Ticker KALA unchanged; split-adjusted trading begins May 11, 2026; new CUSIP 483119301.
Stockholder approved reverse split at January 30, 2026 annual meeting with ratio range of 1-for-2 to 1-for-100.

item 3.03 item 5.03 item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001829126-26-004744
form_type: 8-K
ticker: KALA
cik: 0001479419
company_name: KALA BIO, Inc.
filed_at: 2026-05-07T23:59:59+00:00
discovered_at: 2026-05-14T18:02:32.343653+00:00
generated_at: 2026-05-14T21:35:44.519481+00:00
sec_items: ["3.03", "5.03", "8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.5
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001829126-26-004744
json_url: https://secwatch.observer/filing/0001829126-26-004744.json
markdown_url: https://secwatch.observer/filing/0001829126-26-004744.md
text_url: https://secwatch.observer/filing/0001829126-26-004744.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/0001829126-26-004744-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1479419/000182912626004744/kalabio_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001829126-26-004744

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.